Pure Global AI
NCT06294717Not yet recruiting

The Effect of Progressive Relaxation Exercises on Physiological Parameters, Pain and Anxiety After Cesarean Section

Ataturk UniversityClinicalTrials.govother
Study focus
Disease/Condition
Pain
Drug/Device/Intervention
Progressive relaxation exercises will be applied.
Study type
Interventional
Intervention type
other
Sponsor & location
Primary sponsor
Ataturk University
Timeline & enrollment
Phase
N/A
Start date
Mar 01, 2024
End date
Dec 01, 2024
Enrollment
2 participants
Primary outcome

Beck Anxiety Scale

Summary

Caesarean section is a surgical procedure that can be performed before or during birth in
 cases where the life of the mother and fetus is threatened or upon the request of the mother
 and father. One of the most common problems after cesarean section is abdominal pain.
 Progressive relaxation exercises are a method that allows certain muscle groups in the body
 to first contract and then relax. Progressive relaxation exercises have been proven to have
 positive effects on anxiety. By applying progressive relaxation exercises, the
 parasympathetic nervous system is activated; Thus, heart and respiratory rate and blood
 pressure can be kept within normal limits. This study will be conducted to determine the
 physiological parameters, pain and anxiety levels of progressive relaxation exercises, one of
 the non-pharmacological methods, on women giving birth by cesarean section.

ICD-10 classifications
Pain, unspecifiedPain, not elsewhere classifiedPain in limbAcute painOther chronic pain
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06294717
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06294717 through Pure Global AI's free database. This phase not specified trial is sponsored by Ataturk University and is currently Not yet recruiting. The study focuses on Pain. Target enrollment is 2 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.